My watch list
my.chemeurope.com  

my.chemeurope.com

With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.

  • My watch list
  • My saved searches
  • My saved topics
  • My newsletter
Register free of charge
Login  
eng  
DeutschEnglishFrançaisEspañol

Dapagliflozin



Dapagliflozin
IUPAC name dapagliflozin
Other names BMS-512148
Identifiers
CAS number 461432-26-8
SMILES [H][C@]1(O[C@H](CO)[C@@H](O)
[C@H](O)[C@H]1O)c2cc(Cc3ccc
(OCC)cc3)c(Cl)cc2
InChI InChI=1/C21H25ClO6/c1-2-27-
15-6-3-12(4-7-15)9-
14-10-13(5-8-16(14)22)21-
20(26)19(25)18(24)17(11-
23)28-21/h3-8,10,17-21,
23-26H,2,9,11H2,1H3/t17-,
18-,19+,20-,21+/m1/s1
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)
Infobox disclaimer and references

Dapagliflozin is an experimental SGLT2 inhibitor being studied by Bristol-Myers Squibb as a potential treatment for type 1 and 2 diabetes.[1]

References

  1. ^ http://www.ama-assn.org/ama1/pub/upload/mm/365/dapagliflozin.pdf
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Dapagliflozin". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE